Epidural Clonidine Versus Corticosteroid for Low Back Pain
NCT ID: NCT02239627
Last Updated: 2021-01-20
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
16 participants
INTERVENTIONAL
2014-09-30
2015-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
For those suffering from continued or recurrent low back pain, numerous treatment options exist. One such option is an epidural injection, particularly when other non-surgical treatment options have failed. An epidural injection is the placement of a needle into the space around the spinal cord with the aid of a live X-Ray machine, followed by an injection of various medications. Typically, the medication that is injected is a steroid, commonly with the combination of local anesthetic medication. Epidural steroid injections, with or without local anesthetic is part of the established standard of care in the United States for those with continued or recurrent low back pain. The steroid is believed to reduce inflammation and edema of the injured or irritated nerves. However, despite the routine use of epidural steroids, the steroid itself is not without risks or side effects. Though rare, the steroids have been associated with complications including osteoporosis, steroid induced myopathy, cataracts and many others. In order to minimize the side effects associated with epidural steroids, limiting the dose and frequency have been outlined.
Clonidine is another medication, commonly used in numerous clinical settings. U. S. Food and Drug Administration approved the medication for epidural use for cancer pain but studies have shown effectiveness in non-cancer pain was well and is routinely used for various conditions. There is growing evidence on the use of epidural clonidine for treatment of pain, including low back pain.
This research will study and compare the effectiveness, if any, of clonidine compared to steroid in an epidural injection for low back pain.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Metabolic and Endocrine Effects of Repeated Epidural and Sacroiliac Joint Corticosteroid Injections
NCT01717430
Treatment of Chronic Thoracic and Neck and Upper Extremity Pain
NCT01071369
Added Value of Local Clonidine for Spine Postoperative Pain Control, in Addition to Bupivacaine
NCT01902108
Lidocaine and Ketamine Versus Standard Care on Acute and Chronic Pain
NCT00720330
Regional Anesthesia in Minimally Invasive Lumbar Spine Surgery
NCT05029726
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Steroid
Epidural steroid injection
Epidural steroid
Clonidine
Epidural clonidine injection
Clonidine
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Epidural steroid
Clonidine
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Subject has average pain score (VAS) at least 5
3. Subject has persistent pain despite conservative care
4. Subjects has experienced pain for at least 1 month
5. 18 years of age or older when written informed consent is obtained
6. Signed Institutional Review Board (IRB) approved informed consent form
Exclusion Criteria
2. Coagulopathy
3. Active Infection
4. Serious neurologic deficit
5. Subject is pregnant or planning on becoming pregnant during the course of the study
6. Subject is member of a vulnerable population
7. Investigator suspects substance abuse that might confound the study results
8. Subject has unresolved major issues of secondary gain (as determined by the investigator)
9. Subject exhibits major psychiatric morbidity, untreated or refractory to treatment as determined by the investigator
10. Currently diagnosed with cognitive impairment, or exhibits any characteristic, that would limit study candidate's ability to assess pain relief or complete study assessments
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
West Virginia University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
West Virginia University Hospitals
Morgantown, West Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1407358518
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.